We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$176B
AUM Growth
Cap. Flow
+$177B
Cap. Flow %
100.62%
Top 10 Hldgs %
27.59%
Holding
8,107
New
8,045
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 3.13%
2 Healthcare 1.88%
3 Financials 1.57%
4 Consumer Discretionary 1.26%
5 Energy 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIFL
7901
DELISTED
FOOD TECHNOLOGY SERVICE, INC
VIFL
$58K ﹤0.01%
+11,765
New +$58.5K
IMNN icon
7902
Imunon
IMNN
$9.2M
$57K ﹤0.01%
+5
New +$69.6K
INO icon
7903
Inovio Pharmaceuticals
INO
$122M
$57K ﹤0.01%
+1,502
New +$45.5K
TRX icon
7904
CALL
TRX Gold Corp
TRX
$393M
$56K ﹤0.01%
+20,700
New +$60.2K
OIG
7905
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$56K ﹤0.01%
+254
New +$55.9K
ABCD
7906
DELISTED
Cambium Learning Group, Inc.
ABCD
$56K ﹤0.01%
+44,761
New +$52.1K
MEET
7907
DELISTED
The Meet Group, Inc. Common Stock
MEET
$56K ﹤0.01%
+34,582
New +$60.8K
SVNT
7908
PUT
DELISTED
SAVIENT PHARMACEUTICALS INC
SVNT
$56K ﹤0.01%
+100,600
New +$70.1K
VIRX
7909
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$55K ﹤0.01%
+50
New +$55.7K
QLTI
7910
PUT
DELISTED
QLT Inc
QLTI
$55K ﹤0.01%
+12,500
New +$101K
DM
7911
DELISTED
DOLAN COMPANY COMMON STOCK
DM
$55K ﹤0.01%
+33,678
New +$60.2K
FBN
7912
DELISTED
FURNITURE BRANDS INT'L INC
FBN
$55K ﹤0.01%
+13,812
New +$87.6K
KEM
7913
CALL
DELISTED
KEMET Corporation
KEM
$55K ﹤0.01%
+13,400
New +$68.4K
ENFY
7914
CALL
DELISTED
Enlightify Inc
ENFY
$54K ﹤0.01%
+1,583
New +$56.6K
SGYP
7915
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$54K ﹤0.01%
+12,675
New +$63.7K
SURG
7916
DELISTED
SYNERGETICS USA, INC.
SURG
$54K ﹤0.01%
+13,694
New +$45.2K
REFR icon
7917
Research Frontiers
REFR
$15.5M
$53K ﹤0.01%
+13,224
New +$52.3K
PVA
7918
DELISTED
PENN VIRGINIA CORP
PVA
$53K ﹤0.01%
+11,366
New +$50.1K
CDZI icon
7919
Cadiz
CDZI
$310M
$52K ﹤0.01%
+11,360
New +$64.9K
AAU
7920
PUT
DELISTED
Almaden Minerals Ltd
AAU
$52K ﹤0.01%
+37,000
New +$60.9K
NSPH
7921
PUT
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$52K ﹤0.01%
+855
New +$53.5K
VRML
7922
CALL
DELISTED
Vermillion, Inc.
VRML
$52K ﹤0.01%
+19,300
New +$41.6K
LLEN
7923
CALL
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$52K ﹤0.01%
+14,600
New +$48.9K
FOCL
7924
PUT
EDAP TMS S.A.
FOCL
$155M
$51K ﹤0.01%
+18,600
New +$66.4K
VLTC
7925
DELISTED
Voltari Corporation
VLTC
$51K ﹤0.01%
+14,297
New +$64K

Similar funds

Jeff Yass's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Jeff Yass, which disclosed 8,107 positions worth $176B. Its ten largest holdings account for 28% of the portfolio.

Its largest position is State Street SPDR S&P 500 ETF Trust: 53,029,388 shares worth $8.49B.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, followed by Healthcare and Financials.

  • Jeff Yass's largest Q2 2013 buy was State Street SPDR S&P 500 ETF Trust: 53,029,388 shares worth $8.49B.
  • Jeff Yass's ten largest holdings make up 28% of its $176B portfolio in Q2 2013.
  • Jeff Yass disclosed 8,107 positions in Q2 2013, its first 13F filing on record.

Based on Susquehanna International Group's 13F filing for Q2 2013, filed 13 Aug 2013.